ZAP-X作为专为颅脑精准放疗而设计的革命性设备，凭借独创双回旋球形结构，可实现数千个非共面射 线照射，在提升肿瘤杀伤效率的同时有效降低正常脑组织受量；亚毫米级等中心精度、实时影像引导与 实时剂量监控系统等一系列创新突破，在放疗精度与安全两大核心维度树立了全新标杆。此外，ZAP-X 全球首创完全自屏蔽功能，使放疗设备无需厚重的防护墙，实现"阳光放疗"，优化了患者的治疗环境与 体验。 为加速破解脑肿瘤临床精准治疗的迫切需求，持续验证、挖掘ZAP-X临床价值，优化治疗方案，百洋医 药联手国内顶尖医疗机构加速落地相关临床研究。12月5日，百洋医药与北大国际医院宣布启动ZAP-X 真实世界研究，北大国际医院将依托ZAP-X设备临床应用后的真实世界数据，加速其在脑肿瘤各细分疾 病类型中的价值验证。12月8日，首都医科大学宣武医院同步启动了国内外迄今样本量最大的ZAP-X脑 转移瘤前瞻性IIT研究，该研究主要聚焦ZAP-X在脑转移瘤治疗中的临床疗效、安全性及剂量学特征。 新京报讯(记者张兆慧)12月5日至9日，百洋医药（301015）ZAP-X火星舟放射外科机器人(以下简称 ZAP-X)接连实现全球制造基地投产、临床研究 ...

Core Viewpoint - The collaboration between Peking University International Hospital and Baiyang Pharmaceutical aims to establish a "Precision Radiotherapy Center" utilizing the advanced ZAP-X brain precision radiotherapy robot, addressing the challenges of safety and precision in brain tumor treatments [2][3]. Group 1: Clinical Perspective - The relationship between doctors and tumors is characterized by the need to effectively eliminate the tumor while protecting normal tissues, highlighting the importance of precision and safety in brain radiotherapy [5]. - Traditional high-energy radiotherapy systems often lead to increased scatter risks, making it difficult for doctors to balance efficacy and side effects, which significantly impacts patient experience [6]. - The introduction of ZAP-X allows for a more humane treatment experience, reducing patient discomfort and treatment time while enhancing the confidence of doctors in delivering effective care [6][10]. Group 2: Collaborative Logic - The partnership between the hospital and the pharmaceutical company represents a genuine co-construction rather than a simple supplier-client relationship, focusing on mutual benefits and shared responsibilities [7][8]. - Baiyang Pharmaceutical, as a major stakeholder in ZAP Surgical, not only provides the equipment but also engages in clinical applications and validations, ensuring continuous improvement of the technology [10]. - The establishment of a high-end manufacturing base in Beijing aims to facilitate the domestic production and global delivery of ZAP-X, promoting the localization of advanced medical equipment [10]. Group 3: ZAP-X's Precision Control Logic - ZAP-X utilizes a 3MV linear accelerator, achieving a balance between sufficient energy and controllable energy levels, which minimizes scatter and enhances safety [14][15]. - The system's unique design allows for precise radiation delivery, significantly reducing the dose to healthy tissues and shortening treatment times by approximately 20% [15]. - The comfort and trust established through ZAP-X's technology enhance the overall treatment experience for both doctors and patients, making precision radiotherapy more accessible [15]. Group 4: Future Industry Perspective - The collaboration exemplifies a new medical cooperation ecosystem where both parties share the responsibility for validation and improvement, leveraging real clinical data for continuous optimization [16][17]. - The integration of precision and accessibility in brain radiotherapy transforms it from a high-end medical service to a routine treatment option [18]. - This co-construction model may set a new industry standard, where technology is not only introduced but also applied, validated, and iteratively improved [19][20].

尽管放射外科技术(SRS)已应用数十年，但由于成本、设施与技术问题，仍有近80%患者无法获得高质 量治疗，尤其在良性脑肿瘤、恶性脑肿瘤(多为脑转移瘤)等疾病的治疗方面。 本报讯(记者刘钊)近日，全球规模最大、影响力最广的放射肿瘤学学术盛会——第67届美国放射肿瘤学 会(ASTRO)年会在美国旧金山隆重召开，汇聚了超1万名来自世界各地的顶尖放疗专家、学者。青岛百 洋医药（301015）股份有限公司(以下简称"百洋医药")投资企业——放射外科领域创新者ZAP Surgical 携全球领先的脑肿瘤精准放疗机器人ZAP-X火星舟放射外科机器人首次亮相大会，全面展示了ZAP-X的 最新技术突破与临床成果。 在大会现场，ZAP Surgical创始人兼首席执行官、射波刀发明人约翰艾德勒(JohnR.Adler)分享了ZAP-X 的诞生初衷与技术理念，吸引众多专家学者驻足观摩与交流。现场，一项经同行评审的全新科学研究1 也同步发布。该研究由斯坦福大学、迈阿密癌症研究所等多家机构共同参与完成，结果表明：不同平台 间对健康脑组织的低剂量辐射溢出存在显著差异，最高可达到50倍的差异。ZAP-X在进行脑肿瘤放疗 时，对健康脑组织的 ...